Print

VAX 004

A Phase III Trial to Determine the Efficacy of Bivalent AIDSVAX B/B Vaccine in Adults at Risk of Sexually Transmitted HIV-1 Infection in North America

Trial Details:

III Completed
VaxGen June 01, 1998
AIDSVAX B/B
AIDSVAX B/B Protein
Canada, Netherlands, Puerto Rico, USA 5,400
http://www.clinicaltrials.gov; http://www.actis.org; http://www.vaxgen.com http://www.clinicaltrials.gov; http://www.actis.org; http://www.vaxgen.com